• ثبت نام
    • ورود به سامانه
    مشاهده مورد 
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Iranian Journal of Pharmaceutical Research
    • Volume 19, Issue 2
    • مشاهده مورد
    •   صفحهٔ اصلی
    • نشریات انگلیسی
    • Iranian Journal of Pharmaceutical Research
    • Volume 19, Issue 2
    • مشاهده مورد
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Atorvastatin Sensitizes Breast and Lung Cancer Cells to Ionizing Radiation

    (ندگان)پدیدآور
    Hoseinimehr, Seyed JalalGhasemi, FatemehFlahatgar, FarzanehRahmanian, NajmehGhasemi, ArashAsgarian-Omran, Hossein
    Thumbnail
    دریافت مدرک مشاهده
    FullText
    اندازه فایل: 
    942.5کیلوبایت
    نوع فايل (MIME): 
    PDF
    نوع مدرک
    Text
    Research article
    زبان مدرک
    English
    نمایش کامل رکورد
    چکیده
    Tumour cells may be resistant to radiotherapy that results in unsuccessful cancer treatment in patients. The aim of this study was to evaluate the sensitizing effect of atorvastatin (ATV) on breast cancer (MDA-MB-231) and non-small cell lung cancer (A-549) cells following exposure to ionizing radiation (IR). These cells were treated with ATV and exposed to X-ray at dose 4 Gy. The radiosensitizing effects of ATV were evaluated by flow cytometry and anti-proliferation assays. The production of reactive oxygen species (ROS) was determined in irradiated and treated cells with ATV. The findings of this study showed that ATV increased the percentage of apoptotic cells in irradiated breast and lung cancer cells. ATV exhibited anti-proliferative effect on cancer cells and increased cell death induced by IR. ATV increased ROS production in irradiated cells. The present study demonstrates that ATV has radiosensitizing effect on breast and lung cancer cells through increasing apoptosis, ROS production and cell death induced by IR.
    کلید واژگان
    Atorvastatin
    Radiosensitizing
    Apoptosis
    Ionizing radiation
    Radiosensitizer
    toxicology and Pharmacology

    شماره نشریه
    2
    تاریخ نشر
    2020-06-01
    1399-03-12
    ناشر
    School of Pharmacy, Shahid Beheshti University of Medical Sciences
    سازمان پدید آورنده
    Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
    Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
    Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
    Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
    Department of Radiology and Radiation Oncology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
    Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. |Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

    شاپا
    1735-0328
    1726-6890
    URI
    https://dx.doi.org/10.22037/ijpr.2020.15487.13126
    http://ijpr.sbmu.ac.ir/article_1101018.html
    https://iranjournals.nlai.ir/handle/123456789/312300

    مرور

    همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

    حساب من

    ورود به سامانهثبت نام

    آمار

    مشاهده آمار استفاده

    تازه ترین ها

    تازه ترین مدارک
    © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
    تماس با ما | ارسال بازخورد
    قدرت یافته توسطسیناوب